Clinical Trials Browser

INDUSTRY × Carcinoma, Non-Small-Cell Lung × Sunitinib × Clear all

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular

NCT00428220 2019-06-27

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Adenoma, Islet Cell, Somatostatinoma, Thyroid Neoplasms, Gastrointestinal Stromal Tumors

NCT00864721 2018-10-16

Sunitinib Non Small Cell Lung Cancer Patients Over 70

Phase 2 Completed

63 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00457392 2013-10-29

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Phase 3 Completed

960 enrolled 13 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00265317 2013-02-06

SUN1058

Phase 2 Completed

162 enrolled 53 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00528619 2011-04-08

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

Phase 1 Completed

96 enrolled

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Neoplasms

NCT00372775 2011-02-24

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Phase 2 Completed

66 enrolled 21 charts

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00113516 2010-05-18

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

84 enrolled 40 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00434226 2009-08-21

A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

Phase 2 Terminated

56 enrolled 6 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00712504 2008-11-11

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Phase 1 Completed

49 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00092001 2008-10-16

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

111 enrolled

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Sunitinib Non Small Cell Lung Cancer Patients Over 70

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

SUN1058

A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L)

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer